Colorado House Bill HB1106

Colorado 2024 Regular Session

• Introduced: 1/25/24
• Failed: 3/5/24
• Refer: 1/25/24

Caption

Require Information about Abortion Pill Reversal

Impact

If enacted, HB 1106 would amend existing Colorado Revised Statutes to classify failure to provide information on abortion pill reversal as a deceptive trade practice, resulting in civil penalties and potential professional disciplinary action against non-compliant medical professionals. The Colorado Department of Public Health and Environment would be tasked with maintaining this information on its public website while supporting access to additional resources for women considering reversal of abortion drugs. This act positions state interests in educating women about their options concerning abortion medications.

Summary

House Bill 1106, also known as the 'Abortion Pill Reversal Information Act', mandates that medical professionals provide information about the possibility of reversing medication-induced abortions. Specifically, the bill requires that at least 24 hours prior to prescribing abortion-inducing drugs, physicians must inform women about the potential to reverse the effects of Mifepristone, the first drug in the common two-drug regimen, and provide resources such as a hotline and website. This act aims to ensure that women have comprehensive information available to make fully informed decisions regarding their reproductive health.

Contention

The introduction of HB 1106 has prompted considerable debate surrounding the ethics and medical validity of abortion pill reversal. Proponents argue that women should be provided with all available options, while critics raise concerns that such reversal claims lack robust medical consensus and could potentially mislead patients. Similar bills across the country have faced scrutiny and legal challenges, questioning whether requiring such information could infringe upon reproductive rights or lead to misinformation regarding the safety and effectiveness of reversal procedures.